Results From a Large,Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region

Background

Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.

Credentialed Persons, Credentialed Knowledge

The vast experimental literature on human error agrees with history of medicine, folklore, and superstition In discrediting knowledge claims based solely on anecdotal impressions. Since clinical experience consists of anecdotal impressions by practitioners, tt Is unavoidably a mixture of truths, half-truths, and falsehoods. The scientific method is the only known way to distinguish these, and it is both unscholariy and unethical for psychologists who deal with other persons' health, careers, money, freedom, and even life itself to pretend that clinical experience suffices and that quantitative research on diagnostic and therapeutic procedures is not needed. Disputes about philosophy of science (e.g., logical positivism) are irrelevant to this issue, which is simply one of distinguishing knowledge claims that bring reliable credentials and others that do not.     

浅谈电子文档的原始性和真实性及法律证据作用

该文针对电子文件或档案的原始性真实性与电子档案的法律证据作用,参考了最新的研究结果,并提出了自己的思考,逐步探讨了它们的涵义及关系.     

从医务人员的证据意识谈举证责任倒置

文章从剖宫产术后伴发腰腿痛病例分析入手，认为举证责任倒置就在我们诊疗工作中，就在我们协调医患关系的过程中。因此需要在临床实践中去感悟举证责任置的深刻含义，从而树立证据意识，做好证据的收集与保存工作，一旦发生诉讼有证为据，并由此提出了“医学证据学”的构想，而医学证据的特点有待进一步深入研究。     

Co‐occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines. Part II

Adults with Down syndrome (DS) represent a unique population who are in need of clinical guidelines to address their medical care. Many of these conditions are of public health importance with the potential to develop screening recommendations to improve clinical care for this population. Our workgroup previously identified and prioritized co‐occurring medical conditions in adults with DS. In this study, we again performed detailed literature searches on an additional six medical conditions of clinical importance. A series of key questions (KQ) were formulated a priori to guide the literature search strategy. Our KQs focused on disease prevalence, severity, risk‐factors, methodologies for screening/evaluation, impact on morbidity, and potential costs/benefits. The available evidence was extracted, evaluated and graded on quality. The number of participants and the design of clinical studies varied by condition and were often inadequate for answering most of the KQ. Based upon our review, we provide a summary of the findings on hip dysplasia, menopause, acquired cardiac valve disease, type 2 diabetes mellitus, hematologic disorders, and dysphagia. Minimal evidence demonstrates significant gaps in our clinical knowledge that compromises clinical decision‐making and management of these medically complex individuals. The creation of evidence‐based clinical guidance for this population will not be possible until these gaps are addressed.     

多参数信息融合实现非脑电的睡眠结构分期

目前临床睡眠分析的主要手段是多导睡眠图（Polysomnograph,PSG）,用仪器记录被测者整晚的脑电、眼动电和颏肌电等生理参数,计算机进行自动睡眠分期,再由技术人员依据国际标准进行校正.几十年来PSG保持着睡眠分期金标准的地位.提出在不使用脑电的条件下,利用较易获得的心动周期、呼吸、体动等基本生理参数,提取其中与睡眠过程及其变化有关的规律和信息,建立知识规则库,采用不确定推理的证据理论进行多参数睡眠信息融合计算,实现睡眠结构分期.50余例与PSG对照试验结果表明：醒睡的平均符合率达90%以上,基本睡眠结构的平均符合率达75%以上,证明该技术达到了应用的要求.     

治疗儿童呼吸系统疾病中成药的临床研究证据的概况性综述

目的：该研究使用概况性综述的方法,对治疗儿童呼吸系统疾病的中成药说明书信息及临床研究证据进行全面分析总结并报告。方法：通过检索2021年版《国家基本医疗保险、工商保险和生育保险药品目录》、2018年版《国家基本药物目录》、2020年版《中华人民共和国药典》（一部）,三大药品目录,获得治疗儿童呼吸系统疾病中成药;再检索中英文数据库获得相关文献,最后进行数据统计与可视化分析。结果：经筛选分析后,共纳入中成药52种。涉及9种剂型;主要组成为黄芩、苦杏仁、连翘等;功效以清热解表、止咳化痰等为主;主要治疗小儿风热感冒、咳嗽等;药物不良反应与禁忌证均只有19.23%(10/52)的中成药给与说明,其余均为尚不明确。纳入文献279篇,其中中文核心期刊文献277篇,英文科学引文索引扩展版（SCIE）2篇,包括随机对照研究253篇（含剂型/剂量比较6篇）、基于医院管理信息系统（HIS）数据的回顾性分析11篇、病例系列1篇、系统评价与Meta分析13篇（含网状Meta分析2篇）、经济学评价1篇。72.76%(203/279)的研究发表在中国科技核心期刊上;文献只涉及33种中成药,关于小儿肺热咳喘口服液的研...     

What is the Level of Evidence Substantiating Commercial Payers’ Coverage Policies for Total Joint Arthroplasty?

BackgroundThe prevalence of total joint arthroplasty (TJA) in the United States has drawn the attention of health care stakeholders. The payers have also used a variety of strategies to regulate the medical necessity of these procedures. The purpose of this study was to examine the level of evidence of the coverage policies being used by commercial payers in the United States.MethodsThe references of the coverage policies of four commercial insurance companies were reviewed for type of document, level of evidence, applicability to a TJA population, and success of nonoperative treatment in patients with severe degenerative joint disease.Results282 documents were reviewed. 45.8% were primary journal articles, 14.2% were level I or II, 41.2% were applicable to patients who were candidates for TJA, and 9.9% discussed the success of nonoperative treatment in patients who would be candidates for TJA.ConclusionMost of the references cited by commercial payers are of a lower level of scientific evidence and not applicable to patients considered to be candidates for TJA. This is relatively uniform across the reviewed payers. The dearth of high-quality literature cited by commercial payers reflects the lack of evidence and difficulty in conducting high level studies on the outcomes of nonoperative versus operative treatment for patients with severe, symptomatic osteoarthritis. Patients, surgeons, and payers would all benefit from such studies and we encourage professional societies to strive toward that end through multicenter collaboration.